首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1747972

放射性皮肤炎市场（按产品类型、分销管道和地区）

Radiodermatitis Market, By Product Type, By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: 2025年05月19日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

放射性皮肤炎市场规模预计在 2025 年为 4.428 亿美元，预计到 2032 年将达到 5.946 亿美元，2025 年至 2032 年的复合年增长率为 4.3%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	4.428亿美元
效能数据	2020-2024	预测期	2025-2032
预测期间：2025年至2032年的复合年增长率	4.30%	2032年价值预测	5.946亿美元

放射性皮肤炎 (放射性皮肤炎、放射相关皮肤反应、放射损伤) 是癌症治疗或核袭击和灾难（如 2011 年福岛）期间电离辐射的严重副作用。具体而言，95% 接受放射线治疗的癌症患者会出现某种形式的放射性皮肤炎，包括红斑。放射性皮肤炎可以包括红斑、干性脱屑和湿性脱屑。此类放射引起的皮肤反应会导致无数併发症，包括延迟治疗、美观度差和生活品质下降。最近的技术进步和新治疗方法仅部分成功地减轻了这些有害的副作用。放射性皮肤炎最常见的原因是放射线治疗，用于治疗癌症和其他疾病。灾难和核子袭击也会导致这种情况。分销管道包括零售和线上药局。

市场动态

放射性皮肤炎，又称X光皮疹、放射性皮肤炎、放射性皮肤反应和放射性损伤，是外部电离辐射的副作用。放射性皮肤炎的主要原因是用于治疗癌症和其他疾病的放射线治疗。核袭击和灾难也可能导致放射性皮肤炎。例如，美国生物技术资讯中心（NCBI）于2020年5月14日发表的一篇论文解释说，向患者推荐的产品均未基于循证实践，这些产品在预防或治疗放射性皮肤炎方面的有效性不可信。先前，有研究建议使用尿素霜进行湿润护肤，以有效减轻急性皮肤反应的严重程度。最近的报告还建议使用类固醇、金盏花、贯叶连翘和印楝油来治疗急性放射性皮肤炎。

研究的主要特点

本报告对全球放射性皮肤炎市场进行了详细分析，并以 2024 年为基准年，预测了 2025 年至 2032 年期间的市场规模和年复合成长率(CAGR)。
它还揭示了不同领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，介绍了全球放射性皮肤炎市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球放射性皮肤炎市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过全球放射性皮肤炎市场分析中使用的各种策略矩阵更轻鬆地做出决策。

介绍
北美洲
- 美国
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 东南亚国协
- 澳洲
- 韩国
- 其他亚太地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
非洲
- 北非
- 中部非洲
- 南非

第七章竞争态势

Acelity, Inc.（3M）
BMG Pharma Srl
ConvaTec Group PLC
DermaSciences Inc.（Integra LifeSciences Holdings Corporation）
Intermed Pharmaceuticals
Molnlycke Health Care
Smith & Nephew Plc
Stratpharma AG
Kannalife, Inc.
McKesson Corporation

第 8 章章节

调查方法
关于出版商

简介目录

Product Code: CMI3881

Radiodermatitis Market is estimated to be valued at USD 442.8 Mn in 2025 and is expected to reach USD 594.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 442.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.30%	2032 Value Projection:	USD 594.6 Mn

Radiodermatitis (radiation dermatitis, radiation-related skin reactions, or radiation damage) is a serious side effect of ionizing radiation during cancer therapy and nuclear attacks and disasters such as Fukushima in 2011. Specifically, 95% of cancer patients receiving radiation therapy develop some form of radiation dermatitis, including erythema. , dry scale and moist scale. These skin reactions to radiation lead to countless complications, such as treatment delays, reduced aesthetic appeal, and reduced quality of life. Recent technological advances and new treatment regimens have only partially succeeded in alleviating these harmful side effects. The most common cause of radiation dermatitis is radiation therapy, which is used to treat cancer and other disorders. Disasters and nuclear assaults may also contribute to the condition. Retail pharmacies and online pharmacies are included in the distribution route.

Market Dynamics

Radiation dermatitis, also known as X-ray rash, radiation dermatitis, radiation skin reactions or radiation damage, is a side effect of external ionizing radiation. Radiation therapy, used to treat cancer or other diseases, is a leading cause of radiation dermatitis. Nuclear attacks and disasters can also cause the condition. For instance, on May 14, 2020, an article published by National Center for Biotechnology Information (NCBI) explained none of the recommended products for patients are based on evidence-based practice, and the effectiveness of these products in preventing or treating radiation dermatitis is not reliable. It has previously been suggested that moist skin care with urea cream is effective in reducing the severity of acute skin reactions. In addition, recent reports have recommended the use of steroids, calendula, Hypericum perforatum, and neem oil for the treatment of acute radiodermatitis.

Key features of the study

This report provides an in-depth analysis of the global radiodermatitis market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global radiodermatitis market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Acelity, Inc. (3M), BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation), Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew Plc, Stratpharma AG, Kannalife, Inc., McKesson Corporation.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global radiodermatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiodermatitis market.

Market Segmentation

Global Radiodermatitis Market, By Product Type
- Topical Agents
- Corticosteroids
- Hydrophilic Creams
- Others
- Oral Medication
- Corticosteroids
- Other
- Analgesic & Anti-Inflammatory
- Dressing
- Hydrogel, Hydrocolloid
- No Sting Barrier Film
- Honey Impregnated Dressing
- Silicone coated Dressing
- Others
Global Radiodermatitis Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Radiodermatitis Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Acelity, Inc. (3M)
- BMG Pharma S.r.l.
- ConvaTec Group PLC
- DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
- Intermed Pharmaceuticals
- Molnlycke Health Care
- Smith & Nephew Plc.
- Stratpharma AG
- Kannalife, Inc.
- McKesson Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Radiodermatitis Market, By Product Type, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Topical Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Corticosteroids
  - Hydrophilic Creams
  - Others
Oral Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Corticosteroids
  - Other
Analgesic & Anti-Inflammatory
Dressings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  - Hydrogel
  - Hydrocolloid
  - No Sting Barrier Film
  - Honey Impregnated Dressing
  - Silicone coated Dressing
  - Others

5. Global Radiodermatitis Market, By Distribution Channel, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Radiodermatitis Market, By Region, 2020-2032, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2020-2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Acelity, Inc. (3M)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
BMG Pharma S.r.l.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
ConvaTec Group PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Intermed Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Molnlycke Health Care
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Smith & Nephew Plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Stratpharma AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Kannalife, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
McKesson Corporation
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

8. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

放射性皮肤炎市场（按产品类型、分销管道和地区）

Radiodermatitis Market, By Product Type, By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

市场动态